Maximum Daily Dose of Ivermectin
For standard parasitic infections in adults, the maximum daily dose of ivermectin is 200 mcg/kg as a single dose, though higher doses up to 600 mcg/kg/day for 3 consecutive days have been studied and found safe in clinical trials. 1, 2, 3
Standard Maximum Dosing by Clinical Context
FDA-Approved Maximum Dose
- The FDA label documents that ivermectin has been studied at doses ranging from 30 to 120 mg (333 to 2000 mcg/kg) in healthy volunteers, demonstrating dose-proportional pharmacokinetics and tolerability. 2
- The standard therapeutic dose remains 200 mcg/kg as a single oral dose for most approved indications. 1, 4
Guideline-Recommended Maximum Doses by Indication
Single-Dose Regimens:
- For strongyloidiasis, cutaneous larva migrans, and most parasitic infections: 200 mcg/kg as a single dose 5, 1, 4
- For pediculosis pubis: 250 mcg/kg, repeated in 2 weeks 1
- For head lice (off-label): 400 mcg/kg on days 1 and 8 1
Multi-Day Regimens (Higher Total Exposure):
- For Loeffler's syndrome: 200 mcg/kg once daily for 3 consecutive days 1
- For immunocompromised patients with strongyloidiasis: 200 mcg/kg on days 1,2,15, and 16 1, 4
- For onchocerciasis: 200 mcg/kg monthly for 3 months (combined with doxycycline) 5, 4
- For crusted (Norwegian) scabies: 200 mcg/kg on days 1,2,8,9, and 15 (requires specialist consultation) 1
Research-Supported Higher Doses
Clinical Trial Evidence:
- Doses up to 600 mcg/kg/day for 3 consecutive days have been studied in malaria transmission reduction trials and found to be safe and well-tolerated. 3
- Single doses up to 800 mcg/kg have been used for onchocerciasis treatment. 3
- The FDA label confirms that doses up to 2000 mcg/kg have been administered in pharmacokinetic studies without significant safety concerns. 2
Critical Safety Considerations
Absolute Contraindications to Higher Doses
- Children under 10 years or weighing <15 kg: Ivermectin may cross the blood-brain barrier and cause neurotoxicity in young children; permethrin is recommended instead. 1, 4
- Loiasis co-infection: Always exclude Loa loa infection before treating with ivermectin in anyone who has traveled to endemic regions, as hypermicrofilaremic patients (>8,000 mf/mL) risk severe adverse events including encephalitis. 1, 4
Special Population Warnings
- Elderly and debilitated patients: One study demonstrated increased mortality in this population, though not confirmed in subsequent reports; use with caution. 4
- Severe hepatic impairment: Use with extreme caution, as safety of multiple doses is not established. 1
- Renal impairment: No dose adjustments required. 1, 4
Common Pitfalls to Avoid
- Forgetting repeat doses: For scabies, the 2-week repeat dose at 200 mcg/kg is mandatory due to limited ovicidal activity. 1
- Incorrect food timing: Standard dosing should be taken on an empty stomach with water for optimal bioavailability, though scabies treatment specifically requires administration with food to enhance epidermal penetration. 1, 4
- Inadequate screening: Always exclude loiasis before treating lymphatic filariasis or onchocerciasis, and exclude onchocerciasis before treating loiasis. 4
- Premature concern about treatment failure: Itching may persist for up to 2 weeks after successful treatment due to allergic dermatitis, not treatment failure. 1, 6